Creative Planning Wave Life Sciences Ltd. Transaction History
Creative Planning
- $116 Billion
- Q2 2025
A detailed history of Creative Planning transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Creative Planning holds 11,484 shares of WVE stock, worth $80,847. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,484
Previous 10,623
8.11%
Holding current value
$80,847
Previous $85,000
12.94%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding WVE
# of Institutions
188Shares Held
133MCall Options Held
495KPut Options Held
36.2K-
Ra Capital Management, L.P. Boston, MA18.2MShares$128 Million2.59% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA15MShares$106 Million0.17% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$58.2 Million0.92% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$47.4 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.53MShares$46 Million0.41% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $611M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...